AU2791689A - Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization - Google Patents
Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomizationInfo
- Publication number
- AU2791689A AU2791689A AU27916/89A AU2791689A AU2791689A AU 2791689 A AU2791689 A AU 2791689A AU 27916/89 A AU27916/89 A AU 27916/89A AU 2791689 A AU2791689 A AU 2791689A AU 2791689 A AU2791689 A AU 2791689A
- Authority
- AU
- Australia
- Prior art keywords
- colistin
- tobramycin
- amphotericin
- atomization
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 title 1
- 108010078777 Colistin Proteins 0.000 title 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 title 1
- 229960003942 amphotericin b Drugs 0.000 title 1
- 238000000889 atomisation Methods 0.000 title 1
- 229960003346 colistin Drugs 0.000 title 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 title 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 title 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 title 1
- 229960000707 tobramycin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8716766 | 1987-12-03 | ||
| FR8716766A FR2624015B1 (en) | 1987-12-03 | 1987-12-03 | MEDICINE COMPRISING THE COMBINATION OF COLISTINE, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2791689A true AU2791689A (en) | 1989-07-05 |
Family
ID=9357419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU27916/89A Abandoned AU2791689A (en) | 1987-12-03 | 1988-12-05 | Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0390832A1 (en) |
| AU (1) | AU2791689A (en) |
| FR (1) | FR2624015B1 (en) |
| WO (1) | WO1989005139A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996000576A2 (en) * | 1994-06-28 | 1996-01-11 | Dr. Zerle Gmbh | Novel clinical uses of polyene macrolides |
| DE4440391C1 (en) * | 1994-11-11 | 1996-05-09 | Haider Angelika | Use of aminoglycosides for the diagnosis of barrier disorders |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| EP2414560B1 (en) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Method for coating a surface of a component |
| EP2432531B1 (en) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalation device and nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| CA2781792C (en) | 2009-11-25 | 2019-04-02 | Boehringer Ingelheim International Gmbh | Nebulizer |
| EP2585151B1 (en) | 2010-06-24 | 2018-04-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| EP2694220B1 (en) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medical device comprising a container |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (en) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Atomiser with coding means |
| US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| ES2836977T3 (en) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizer |
| PL3139979T3 (en) | 2014-05-07 | 2023-12-27 | Boehringer Ingelheim International Gmbh | UNIT, NEBULIZER AND METHOD |
| DK3139984T3 (en) | 2014-05-07 | 2021-07-19 | Boehringer Ingelheim Int | Atomizer |
| NZ724724A (en) | 2014-05-07 | 2022-01-28 | Boehringer Ingelheim Int | Container, indicator device, and nebulizer |
-
1987
- 1987-12-03 FR FR8716766A patent/FR2624015B1/en not_active Expired - Lifetime
-
1988
- 1988-12-05 AU AU27916/89A patent/AU2791689A/en not_active Abandoned
- 1988-12-05 WO PCT/FR1988/000593 patent/WO1989005139A1/en not_active Ceased
- 1988-12-05 EP EP19890900266 patent/EP0390832A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP0390832A1 (en) | 1990-10-10 |
| FR2624015B1 (en) | 1990-06-29 |
| FR2624015A1 (en) | 1989-06-09 |
| WO1989005139A1 (en) | 1989-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2791689A (en) | Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization | |
| IE870993L (en) | Nasal administration compositions. | |
| AU627845B2 (en) | Improvements in or relating to devices for administration of drugs or the like | |
| AU6734990A (en) | Freeze-dried dosage forms and methods for preparing the same | |
| AU7378987A (en) | Drug delivery device, its preparation and use | |
| AU2614088A (en) | Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying | |
| AU3063389A (en) | Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions | |
| AU2624888A (en) | Drug comprising the association of polymyxin b, netilmycin and amphotericin b, administered by spraying | |
| AU650261B2 (en) | Derivatives of glycinamide, their preparation and medicaments containing them | |
| AU622007B2 (en) | Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions | |
| AU652784B2 (en) | Combination of hyaluronic acid with medicinal ingredient and production thereof | |
| AU5449590A (en) | Anti-hiv drug | |
| AU5493190A (en) | Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them | |
| HUT47233A (en) | Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients | |
| AU7143887A (en) | Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs | |
| AU5360890A (en) | Substituted azetidinylisothiazolopyridone derivatives, their preparation and their application as medicinal products | |
| AU4442996A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them | |
| AU8282187A (en) | 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses | |
| AU4560096A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them | |
| AU1741388A (en) | Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of same | |
| AU1638488A (en) | Organo-metal compositions, preparation and use | |
| AU2738088A (en) | Soluble recombinant fce-receptor, the preparation and the use thereof | |
| AU7111587A (en) | Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use | |
| AU1884788A (en) | Alpha-fluoroketones, their preparation, and intermediates | |
| AU2996192A (en) | Intermediates in the preparation of 5-substituted-2, 4-diphenylpyrimidine derivatives |